Clinical Trial Update: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oregovomab in combination with chemotherapy in the neoadjuvant setting for newly diagnosed advanced epithelial ovarian cancer; trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Ovarian Serous Carcinoma
• Peritoneal Cancer

Drugs mentioned

• Oregovomab (oregovomab)

Snippet

Sponsor: CanariaBio Inc. | Conditions: Ovarian Neoplasm Epithelial, Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING